HSP90 inhibitors promote cell death by degrading Met and BCR::ABL1 in both imatinib-resistant and -sensitive chronic myeloid leukemia cells.
Saved in:
| Title: | HSP90 inhibitors promote cell death by degrading Met and BCR::ABL1 in both imatinib-resistant and -sensitive chronic myeloid leukemia cells. |
|---|---|
| Authors: | Tsubaki, Masanobu1 (AUTHOR) tsubaki@kph.bunri-u.ac.jp, Matsuo, Taira1 (AUTHOR), Komori, Rie1 (AUTHOR), Nagai, Noriaki2 (AUTHOR), Yamamoto, Tetsushi2 (AUTHOR), Nishida, Shozo2 (AUTHOR) nishida@phar.kindai.ac.jp |
| Source: | Future Journal of Pharmaceutical Sciences. 1/27/2025, Vol. 11 Issue 1, p1-11. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 23147245 |
|---|---|
| DOI: | 10.1186/s43094-025-00767-w |
